MedPath

Calcium

Generic Name
Calcium
Drug Type
Small Molecule
Chemical Formula
Ca
CAS Number
7440-70-2
Unique Ingredient Identifier
SY7Q814VUP

Overview

Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. The skeleton acts as a major mineral storage site for the element and releases Ca2+ ions into the bloodstream under controlled conditions. Circulating calcium is either in the free, ionized form or bound to blood proteins such as serum albumin. Although calcium flow to and from the bone is neutral, about 5 mmol is turned over a day. Bone serves as an important storage point for calcium, as it contains 99% of the total body calcium. Low calcium intake may also be a risk factor in the development of osteoporosis. The best-absorbed form of calcium from a pill is a calcium salt like carbonate or phosphate. Calcium gluconate and calcium lactate are absorbed well by pregnant women. Seniors absorb calcium lactate, gluconate and citrate better unless they take their calcium supplement with a full breakfast.

Indication

Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. It is vital in cell signaling, muscular contractions, bone health, and signalling cascades.

Associated Conditions

  • Calcium Deficiency
  • Deficiency, Vitamin D
  • Osteodystrophy
  • Osteomalacia
  • Osteoporosis
  • Chronic Hypocalcemia
  • Chronic Hypocalcemia caused by anticonvulsant medications

Research Report

Published: Jul 18, 2025

An Evidence-Based Monograph on Calcium: From Elemental Properties to Clinical Controversies

Section 1: Identification and Physicochemical Profile

This section establishes the fundamental identity of calcium, grounding the subsequent pharmacological and clinical discussion in its basic chemical and physical nature. Calcium, as both a fundamental element and a therapeutic agent, possesses a unique profile that dictates its handling, reactivity, and biological function.

1.1 Nomenclature and Identification

The subject of this monograph is the chemical element Calcium, which is identified in pharmaceutical and chemical databases by a set of unique identifiers. In the DrugBank database, it is classified as a small molecule with the accession number DB01373.[1] The Chemical Abstracts Service (CAS) has assigned it the registration number 7440-70-2, which specifically refers to the elemental form of calcium.[2]

The element is known by several synonyms across different languages and contexts, including "Calcium, elemental," "Elemental calcium," "Calcio" (Spanish), and "Kalzium" (German).[1] In chemical and industrial settings, it is commonly referred to as "Calcium Metal".[4] Its European Community (EC) number is 231-179-5.[2] While the DrugBank entry DB01373 refers to the therapeutic entity, the CAS number 7440-70-2 pertains to the pure element itself. This distinction is important, as the therapeutic applications invariably involve calcium salts rather than the highly reactive elemental metal.

1.2 Atomic and Chemical Properties

Calcium's position in the periodic table defines its chemical behavior. It is an alkaline earth metal, located in Group 2 and Period 4, and belongs to the s-block elements.[9] Its properties are characteristic of the heavier elements in its group, including strontium and barium.[9]

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/08/03
Not Applicable
Not yet recruiting
2025/08/01
Not Applicable
Recruiting
2025/07/17
Not Applicable
Not yet recruiting
Minia University
2025/07/09
Not Applicable
Recruiting
Zhejiang Doer Biologics Co., Ltd.
2025/06/11
Phase 2
Not yet recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
2025/04/16
Not Applicable
Recruiting
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
2025/02/12
Phase 2
Not yet recruiting
Komal Ashraf Khan
2025/02/04
Phase 4
Completed
2025/01/16
Not Applicable
Completed
2025/01/08
Not Applicable
Not yet recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Avion Pharmaceuticals, LLC
75854-313
ORAL
155 mg in 1 1
1/7/2021
Avion Pharmaceuticals, LLC
75854-312
ORAL
155 mg in 1 1
1/7/2021
PruGen, Inc. Pharmaceuticals
42546-300
ORAL
124.1 mg in 1 1
2/22/2013
Acella Pharmaceuticals, LLC
42192-321
ORAL
140 mg in 1 1
1/5/2018
METHOD PHARMACEUTICALS, LLC
58657-170
ORAL
200 mg in 1 1
12/10/2023
Avion Pharmaceuticals, LLC
75854-314
ORAL
155 mg in 1 1
1/7/2021
Pharmics, Inc.
0813-0202
ORAL
200 mg in 1 1
9/6/2012
Bryant Ranch Prepack
63629-3545
ORAL
200 mg in 1 1
7/17/2014
Exeltis USA, Inc.
0642-0079
ORAL
100 mg in 1 1
12/31/2022
Acella Pharmaceuticals, LLC
42192-323
ORAL
160 mg in 1 1
9/11/2018

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
LIQUID CALCIUM MG PHOSPHORUS AND VIT.D-3
organika health products inc.
02053675
Liquid - Oral
600 MG / 15 ML
12/31/1993
COMPLETE MULTI TAB
gahler enterprises ltd.
00477354
Tablet - Oral
125 MG
12/31/1979
CALCIMAG TAB
les produits naturels suisse inc.
00555363
Tablet - Oral
158 MG / TAB
12/31/1985
SWISS ONE
swiss herbal remedies ltd.
00579785
Tablet - Oral
130 MG
12/31/1981
OSTEO FORMULA
nutramed laboratories inc.
02239456
Tablet - Oral
600 MG
N/A
CALAMINE LOTION USP
produits marc-o (1987) inc., division of technilab inc.
00458511
Lotion - Topical
54.6 ML / 100 ML
12/31/1978
ANAPLEX TAB
anabolic laboratories inc.
00299820
Tablet - Oral
160 MG / TAB
12/31/1975
FORMULA INF
balance plus, inc.
02241072
Capsule - Oral
125 MG / CAP
2/9/2000
CALCI A AND D TAB
pharmetics (2011) inc
00479144
Tablet - Oral
165 MG
12/31/1981
CALCITOL
frega inc.
00478830
Capsule - Oral
165 MG / CAP
12/31/1979

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
MASTICAL D 500 MG/1000 UI COMPRIMIDOS MASTICABLES SABOR FRESA
79937
COMPRIMIDO MASTICABLE
Medicamento Sujeto A Prescripción Médica
Commercialized
ELEVIT COMPRIMIDOS RECUBIERTOS CON PELICULA
Bayer Hispania S.L.
67267
COMPRIMIDO RECUBIERTO CON PELÍCULA
Sin Receta
Not Commercialized
MASTICAL D 500 MG/400 UI COMPRIMIDOS MASTICABLES SABOR FRESA
79938
COMPRIMIDO MASTICABLE
Medicamento Sujeto A Prescripción Médica
Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.